FDA Approved: INSULIN LISPRO — Supplemental Application (Eli Lilly and Company)

View source ↗

Summary

FDA approved a supplemental application for Eli Lilly’s insulin lispro, including a diluent component, updating the product’s labeling/administration details.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus
• Type 2 Diabetes Mellitus

Drugs mentioned

• DILUENT (diluents)
• insulin lispro (insulin lispro)

Snippet

SUPPL AP for INSULIN LISPRO (INSULIN LISPRO)